Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 4Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Gastrointestinal 2Tumor-Agnostic 1Thoracic 1Myeloid 1Classical hematology 1Breast 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Gastrointestinal Neoplasms 1Adenocarcinoma 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Induction Chemotherapy × Gastrointestinal × Clear all
NCT01827553 2024-04-11

CONKO-007

University of Erlangen-Nürnberg Medical School

Phase 3 Completed
830 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02454647 2015-05-28

Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients

Clinica Universidad de Navarra, Universidad de Navarra

Completed
46 enrolled
Gastrointestinal

Adenocarcinoma, Gastrointestinal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡